Delivery Order SPE2DR25D6044-SPE2DR26FYA0E
- Not listed
- The Defense Logistics Agency awarded a $1,842.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL quantities. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is non-competitive and scheduled for completion by August 1, 2025. Performance will be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $1,886.24 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5ML quantities. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 22, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in a 5 mL unit, with a ceiling value of $1,267.04. This competitive award utilizes a firm fixed price structure and is classified as a child contract under a larger vehicle. The performance location is identified as Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. No set-aside designation was applied...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $1,240.45 firm fixed-price contract is for the delivery of Loteprednol Etabonate 0.5% ophthalmic drops. The order has a completion date of June 23, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This delivery order, valued at $2,630.16, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp for the supply of Loteprednol Etabonate 0.5% ophthalmic suspension. The contract is a firm fixed-price delivery order issued under the Defense Logistics Agency's Medical Supply Chain program, with performance to be completed by August 19, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis, consistent with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.23 delivery order contract is for the supply of the pharmaceutical product Loteprednol Etabonate 0.5% Ophthalmic Drops, 5 ML. The contract is not designated as a set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,273.07 firm fixed-price delivery order is for the supply of loteprednol etabonate 0.5% eye drops, a medication used for the treatment of various eye conditions. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a $3,964.93 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of LOTEPREDNOL ETABONATE 0.5% DRP 10ML, a pharmaceutical product. The contract has an ultimate completion date of June 11, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,640.84 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% Eye Drops, 5 ml, with a completion date of July 25, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.82 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% ophthalmic drops (5ml). The contract was awarded on September 7, 2021, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System...
- SPE2DR25D6044Indefinite Delivery Contract
- SPE2DR25D6044-SPE2DR26FYA0EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 milliliter units, with a ceiling value of $1,650.30 and an ultimate completion date of October 22, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a prime vehicle valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard, with an extensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. The loteprednol etabonate ophthalmic medication fulfills critical medical supply needs for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/21/25 |